Lack of replication of association findings in complex disease: an analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer's disease

Article metrics

Abstract

There is considerable enthusiasm for the prospect of using common polymorphisms (primarily single nucleotide polymorphisms; SNPs) in candidate genes to unravel the genetics of complex disease. This approach has generated a number of findings of loci which are significantly associated with sporadic Alzheimer's disease (AD). In the present study, a total of 15 genes of interest were chosen from among the previously published reports of significant association in AD. Genotyping was performed on polymorphisms within those genes (14 SNPs and one deletion) using Dynamic Allele Specific Hybridization (DASH) in 204 Swedish patients with sporadic late-onset AD and 186 Swedish control subjects. The genes chosen for analysis were; low-density lipoprotein receptor-related protein (LRP1), angiotensin converting enzyme (DCP1), alpha-2-macroglobulin (A2M), bleomycin hydrolase (BLMH), dihydrolipoyl S-succinyltransferase (DLST), tumour necrosis factor receptor superfamily member 6 (TNFRSF6), nitric oxide synthase (NOS3), presenilin 1 (PSEN1), presenilin 2 (PSEN2), butyrylcholinesterase (BCHE), Fe65 (APBB1), oestrogen receptor alpha (ESR1), cathepsin D (CTSD), methylenetetrahydrofolate reductase (MTHFR), and interleukin 1A (IL1A). We found no strong evidence of association for any of these loci with AD in this population. While the possibility exists that the genes analysed are involved in AD (ie they have weak effects and/or are population specific), results reinforce the need for extensive replication studies if we are to be successful in defining true risk factors in complex diseases.

References

  1. 1

    Hebert LE, Scherr PA, Beckett LA et al. Age-specific incidence of Alzheimer's disease in a community population JAMA 1995 273: 1354–1359

  2. 2

    Goate A, Chartier-Harlin M-C, Mullan M et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease Nature 1991 349: 704–706

  3. 3

    Sherrington R, Rogaev EI, Liang Y et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease Nature 1995 375: 754–760

  4. 4

    Rogaev EI, Sherrington R, Rogaeva EA et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene Nature 1995 376: 775–778

  5. 5

    Levy-Lahad E, Wasco W, Poorkaj P et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus Science 1995 269: 973–977

  6. 6

    Campion D, Dumanchin C, Hannequin D et al. Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum Am J Hum Genet 1999 65: 664–670

  7. 7

    Strittmatter WJ, Saunders AM, Schmechel D et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease Proc Natl Acad Sci 1993 90: 1977–1981

  8. 8

    Saunders AM, Strittmatter WJ, Schmechel D et al. Association of apolipoprotein E allele epsilon 4 with late-onset Alzheimer's disease Neurology 1993 43: 1467–1472

  9. 9

    Roses AD, Saunders AM . APOE is a major susceptibility gene for Alzheimer's disease Curr Opin Biotechnol 1994 5: 663–667

  10. 10

    Slooter AJ, Cruts M, Kalmijn S et al. Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study Arch Neurol 1998 55: 964–968

  11. 11

    Daw EW, Payami H, Nemens EJ et al. The number of trait loci in late-onset Alzheimer's disease Am J Hum Genet 2000 66: 196–204

  12. 12

    Blacker D, Wilcox MA, Laird NM et al. Alpha-2 macroglobulin is genetically associated with Alzheimer's disease Nat Genet 1998 19: 357–360

  13. 13

    Nicoll JA, Mrak RE, Graham DI et al. Association of interleukin-1 gene polymorphisms with Alzheimer's disease Ann Neurol 2000 47: 365–368

  14. 14

    Grimaldi LM, Casadei VM, Ferri C et al. Association of early-onset Alzheimer's disease with an interleukin-1alpha gene polymorphism Ann Neurol 2000 47: 361–365

  15. 15

    Kehoe PG, Russ C, McIlory S et al. Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer's disease Nat Genet 1999 21: 71–72

  16. 16

    Dahiyat M, Cumming A, Harrington C et al. Association between Alzheimer's disease and the NOS3 gene Ann Neurol 1999 46: 664–667

  17. 17

    van Duijn CM, Cruts M, Theuns J et al. Genetic association of the presenilin-1 regulatory region with early-onset Alzheimer's disease in a population-based sample Eur J Hum Genet 1999 7: 801–806

  18. 18

    Brookes AJ, Howell WM, Woodburn K, Johnstone EC, Carothers A . Presenilin-I, presenilin-II, and VLDL-R associations in early onset Alzheimer's disease Lancet 1997 350: 336–337

  19. 19

    Lehmann DJ, Johnson C, Smith AD . Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease Hum Mol Genet 1997 6: 1933–1936

  20. 20

    Nakano K, Ohta S, Nishimaki K, Miki T, Matuda S . Alzheimer's disease and DLST genotype Lancet 1997 350: 1367–1368

  21. 21

    Hu Q, Kukull WA, Bressler SL et al. The human FE65 gene: genomic structure and an intronic biallelic polymorphism associated with sporadic dementia of the Alzheimer type Hum Genet 1998 103: 295–303

  22. 22

    Brandi ML, Becherini L, Gennari L et al. Association of the estrogen receptor alpha gene polymorphisms with sporadic Alzheimer's disease Biochem Biophys Res Commun 1999 265: 335–338

  23. 23

    Papassotiropoulos A, Bagli M, Kurz A et al. A genetic variation of cathepsin D is a major risk factor for Alzheimer's disease Ann Neurol 2000 47: 399–403

  24. 24

    Kang DE, Saitoh T, Chen X et al. Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease Neurology 1997 49: 56–61

  25. 25

    Montoya SE, Aston CE, DeKosky ST, Kamboh MI, Lazo JS, Ferrell RE . Bleomycin hydrolase is associated with risk of sporadic Alzheimer's disease Nat Genet 1998 18: 211–212

  26. 26

    Feuk L, Prince JA, Emahazion T, Breen G, StClair D, Brookes AJ . Apolipoprotein-E dependent role for the FAS receptor in early onset Alzheimer's disease: positive association finding for a polymorphism in the TNFRSF6 gene Human Genetics 2000 107: 391–396

  27. 27

    Cohen B . Freely associating Nat Genet 1999 22: 1–2

  28. 28

    Blennow K, Ricksten A, Prince JA et al. No association between the alpha2-macroglobulin (A2M) deletion and Alzheimer's disease, and no change in A2M mRNA, protein, or protein expression J Neural Transm 2000 107: 1065–1079

  29. 29

    McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM . Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of department of health and human services task force on Alzheimer's disease Neurology 1984 34: 939–944

  30. 30

    Mirra SS, Heyman A, McKeel D . The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease Neurology 1991 41: 479–486

  31. 31

    Bogdanovic N, Morris JH . Diagnostic criteria for Alzheimer's disease in multicentre brain banking in Neuropathological Diagnostic Criteria for Brain Banking Biomedical and Health Research Series IOS Press pp 20–29

  32. 32

    Folstein M, Folstein S, McHugh P . “Mini-Mental State” A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 1975 12: 189–198

  33. 33

    Howell WM, Jobs M, Gyllensten U, Brookes AJ . Dynamic allele-specific hybridization. A new method for scoring single nucleotide polymorphisms Nat Biotechnol 1999 17: 87–88

  34. 34

    Prince JA, Feuk L, Emahazion T, Jobs M, Howell WM, Brookes AJ . Robust and accurate single nucleotide polymorphism genotyping by dynamic allele specific hybridization (DASH): design criteria and assay validation Genome Res 2000 11: 152–162

  35. 35

    Jackson JEA . A user's guide to principal components Wiley, NY 1991

  36. 36

    Wold S, Ruhe A, Wold H, Dunn III WJ . The collinearity problem in linear regression. The partial least squares approach to generalised inverses J Sci Stat Comput 1984 5: 735–743

  37. 37

    Linusson A, Gottfries J, Lindgren F, Wold S . Statistical molecular design of building blocks for combinatorial chemistry J Med Chem 2000 43: 1320–1328

  38. 38

    Gottfries J, Blennow K, Wallin A, Gottfries CG . Diagnosis of dementias using partial least squares discriminant analysis Dementia 1995 6: 83–88

  39. 39

    Wold S . Cross-validatory estimation of the number of components in factor and principal component models Technometrics 1978 20: 397–405

  40. 40

    Martin ER, Lai EH, Gilbert JR et al. SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer's disease Am J Hum Genet 2000 67: 383–394

  41. 41

    Collins A, Lonjou C, Morton NE . Genetic epidemiology of single-nucleotide polymorphisms Proc Natl Acad Sci 1999 96: 15173–15177

Download references

Acknowledgements

Generous financial support has been provided by; The Swedish Brain Fund, and the AMF Jubileum Fund, Tore Nilsons Foundation for Medical Research, Loo Ostermans Foundation, The Swedish Old Servants Foundation (Gamla Tjänarinnor), and Carl Tryggers Foundation for Scientific Research.

Author information

Correspondence to Jonathan A Prince.

Rights and permissions

Reprints and Permissions

About this article

Keywords

  • SNP
  • DASH
  • polymorphism
  • Alzheimer's
  • sporadic
  • association

Further reading